Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report 2017

1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.2.1 Type I

1.2.2 Type II

1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.3.1 Application 1

1.3.2 Application 2

1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market by Regions

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 Japan Status and Prospect (2012-2022)

1.4.5 Southeast Asia Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2022)

1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)

1.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Competition by Manufacturers, Type and Application

2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers

2.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2012-2017)

2.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2012-2017)

2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type

2.2.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)

2.2.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)

2.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Regions

2.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)

2.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)

2.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

3.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

3.1.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

3.1.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

3.1.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

3.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

3.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

3.4 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

4.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

4.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

4.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

4.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

4.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

4.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

5 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

5.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

5.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

5.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

5.1.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

5.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

5.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

6 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

6.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

6.1.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

6.1.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

6.1.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

6.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

6.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

6.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

7 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

7.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

7.1.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

7.2 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

7.3 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

7.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

8 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)

8.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)

8.1.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

8.1.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

8.1.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

8.2 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers

8.3 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type

8.4 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis

9.1 Conatus Pharmaceuticals

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Daewoong Pharmaceutical

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Galmed International

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Kyorin Pharmaceutical

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Metabolic Solutions Development

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Novartis AG

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 Phenex Pharmaceuticals

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Raptor Pharmaceuticals

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 TCM Biotech International

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 Tobira Therapeutics

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Verva Pharmaceuticals

9.12 Zafgen

10 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Maufacturing Cost Analysis

10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

10.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2017-2022)

14.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Price Forecast (2017-2022)

14.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)

14.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price and Trend Forecast (2017-2022)

14.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue and Price Forecast by Type (2017-2022)

14.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Global Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2022)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2022)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales of Key Manufacturers (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers (2012-2017)

Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers

Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Manufacturers

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue by Manufacturers (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2012-2017)

Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers

Table 2016 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Type (2012-2017)

Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Type (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Type (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Regions (2012-2017)

Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2012-2017)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Regions (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Regions (2012-2017)

Figure Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions (2012-2017)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Growth Rate by Regions (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application (2012-2017)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Share by Application (2012-2017)

Figure Sales Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application (2012-2017)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Growth Rate by Application (2012-2017)

Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)

Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)

Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)

Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)

Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)

Table United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)

Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)

Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)

Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)

Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)

Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)

Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)

Table Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)

Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)

Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)

Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)

Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)

Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)

Table Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)

Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)

Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)

Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)

Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)

Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)

Table Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)

Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)

Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)

Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)

Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Manufacturers (2012-2017)

Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Manufacturers (2012-2017)

Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type (2012-2017)

Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Type (2012-2017)

Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application (2012-2017)

Table India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share by Application (2012-2017)

Table Conatus Pharmaceuticals Basic Information List

Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Daewoong Pharmaceutical Basic Information List

Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Galmed International Basic Information List

Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Kyorin Pharmaceutical Basic Information List

Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Metabolic Solutions Development Basic Information List

Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Novartis AG Basic Information List

Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Phenex Pharmaceuticals Basic Information List

Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Raptor Pharmaceuticals Basic Information List

Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table TCM Biotech International Basic Information List

Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Tobira Therapeutics Basic Information List

Table Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Global Market Share (2012-2017)

Table Verva Pharmaceuticals Basic Information List

Table Zafgen Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis

Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Table Distributors/Traders List

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Forecast (2017-2022)

Figure Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2022)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2017-2022)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2022)

Table Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2022)